KPV

Description

KPV

KPV is a research-grade tripeptide made up of lysine, proline, and valine. It is derived from the C-terminal portion of alpha-melanocyte-stimulating hormone (alpha-MSH) and is widely studied for its anti-inflammatory, antimicrobial, and gut-supportive properties.

Unlike the full alpha-MSH sequence, KPV is commonly investigated for its inflammatory pathway activity without the pigmentation-related effects associated with broader melanocortin receptor activation.

Research Overview

KPV has become a compound of interest in studies involving inflammation regulation, intestinal barrier function, wound repair, and immune response signaling. Its small tripeptide structure allows researchers to examine both receptor-mediated and direct cellular mechanisms involved in localized anti-inflammatory activity.

Areas of Scientific Interest

Intestinal Inflammation Research

KPV is frequently studied in gastrointestinal and inflammatory bowel disease models. Preclinical investigations have explored its potential role in:

• Reducing colonic inflammation
• Supporting gut barrier integrity
• Modulating inflammatory cytokines
• Protecting intestinal epithelial tissue
• IBD-like inflammatory models

Research has specifically examined KPV’s relationship with cytokines such as TNF-alpha, IL-6, and IL-1 beta in controlled experimental settings.

Wound Healing & Tissue Repair

KPV has also been evaluated in dermal repair models due to its anti-inflammatory activity at wound sites. Areas of interest include:

• Wound closure studies
• Skin inflammation research
• Tissue recovery models
• Local immune response regulation

Antimicrobial Research

In addition to inflammatory pathway studies, KPV has been investigated for direct antimicrobial activity against certain pathogens, including Candida albicans and Staphylococcus aureus, making it a subject of interest in host-defense and infection-related research models.

Systemic Inflammation Models

Beyond gut and skin research, KPV is studied in broader inflammatory models involving systemic immune activation, sepsis-like responses, and multi-organ inflammatory signaling.

Mechanism of Action

KPV is believed to influence inflammation through several pathways, including melanocortin receptor interaction where applicable, inhibition of NF-kB signaling, and modulation of MAPK-related inflammatory cascades.

Research also suggests KPV may be taken up directly by intestinal epithelial cells through peptide transport systems such as PepT1, allowing investigation into localized intracellular anti-inflammatory effects.

Delivery System Research

Because of its small structure and gut-focused activity, KPV has been studied in advanced delivery systems such as hydrogels and nanoparticles. These models are commonly used to explore targeted colon delivery and localized intestinal inflammation control.

Purity & Quality

Our KPV is manufactured to research-grade standards and verified at >98% purity through HPLC analysis. Each vial contains lyophilized peptide intended for laboratory reconstitution and experimental research applications.

Disclaimer

For laboratory research use only.
Not intended for human consumption, medical treatment, or therapeutic application. This product is not intended to diagnose, treat, cure, or prevent any disease.